REFERENCES

1. Rigamonti D, Vivas-Buitrago T. A brief history of cerebral cavernous malformations: a personal perspective. Vessel Plus 2021;5:47.

2. Lee C. Unique contribution of one patient advocacy organization in advancing cerebral cavernous malformation research. Vessel Plus .

3. Ricci C, Riolo G, Battistini S. Molecular genetic analysis of cerebral cavernous malformations: an update. Vessel Plus 2021;5:31.

4. Finetti F, Trabalzini L. Non-autonomous effects of CCM genes loss. Vessel Plus 2021;5:29.

5. Antwi-adjei E, Burguete AS, Ghabrial AS. Furry is a component of the CCM3-GCKIII signaling pathway. Vessel Plus 2021;5:35.

6. Zhang J, Abou-Fadel JS. Calm the raging hormone - a new therapeutic strategy involving progesterone-signaling for hemorrhagic CCMs. Vessel Plus 2021;5:48.

7. Abou-Fadel J, Bhalli M, Grajeda B, Zhang J. Disrupting the CmP signaling network unveils novel biomarkers for triple negative breast cancer in Caucasian American women. bioRxiv 2021; doi: 10.1101/2021.09.13.460145.

8. Abou-Fadel J, Grajeda B, Jiang X, et al. CmP signaling network unveils novel biomarkers for triple negative breast cancer in African American women. bioRxiv 2021; doi: 10.1101/2021.05.24.445510.

9. Abou-Fadel J, Jiang X, Grajeda B, Padarti A, Ellis C, Zhang J. CCM signaling complex (CSC) coupling both classic and non-classic progesterone receptor signaling. bioRxiv 2020; doi: 10.1101/2020.05.24.112847.

10. Abou-Fadel J, Jiang X, Padarti A, et al. CCM signaling complex (CSC) is a master regulator governing homeostasis of progesterone and its mediated signaling cascades. bioRxiv 2020; doi: 10.1101/2020.06.10.145003.